article Open access

CViTS-Net: A CNN-ViT Network With Skip Connections for Histopathology Image Classification

  • IEEE Access
  • Institute of Electrical and Electronics Engineers
Research footprint

At a glance

Citations
25
References
112
Comments
0
Paper overview

Abstract

Histopathological image classification stands as a cornerstone in the pathological diagnosis workflow, yet it remains challenging due to the inherent complexity of histopathological images. Recently, transformers and convolutional neural network (CNN) - based deep models have shown promising results in the automatic histopathology image classification. Transformers excel at capturing global dependencies within the image content, while CNNs effectively extract local features. In this study, we introduce the CViTS-Net model, a novel deep learning architecture that combines CNNs with vision transformer (ViT), enhanced by innovative skip connections. This fusion allows our model to capture both local and global dependencies within histopathological images. Extensive experiments were conducted, including holdout validation and cross-validation, comparing CViTS-Net with several state-of-the-art CNN, ViT, and attention-based methods on the Chaoyang histopathology dataset. Furthermore, we evaluated the model’s generalizability and robustness by testing it on large and diverse datasets such as lymphoma dataset and invasive ductal carcinoma (IDC) dataset. Our model achieves remarkable classification accuracy of 96.06% on the Chaoyang dataset, 99.61% accuracy on the lymphoma dataset, and 95% accuracy on IDC dataset, surpassing state-of-the-art deep learning models while maintaining superior efficiency. The CViTS-Net model showcases outstanding classification performance, underscoring its potential to significantly aid pathologists in histopathological diagnosis.

Record transparency

Publication details

DOI
10.1109/access.2024.3448302
OpenAlex
W4401795678
Document type
article
Language
EN
Source
IEEE Access
Last metadata update
Community

Comments

Log in to join the discussion.

  1. No comments yet. Start the discussion.